Renske M.T. ten Ham

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

Maartje W. Rohaan, Troels Holz Borch, Joost H. van den Berg et al. · New England Journal of Medicine · 2022 · 474 citations · Full text

Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe

Renske M.T. ten Ham, Jarno Hoekman, Anke M. Hövels et al. · Molecular Therapy — Methods & Clinical Development · 2018 · 101 citations · Full text

What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings

Renske M.T. ten Ham, Anke M. Hövels, Jarno Hoekman et al. · Cytotherapy · 2020 · 60 citations · Full text

Estimation of manufacturing development costs of cell-based therapies: a feasibility study

Renske M.T. ten Ham, Julianne C. Nievaart, Jarno Hoekman et al. · Cytotherapy · 2021 · 26 citations · Full text

Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and Zolgensma

Frederick W. Thielen, Renaud Heine, Sibren van den Berg et al. · Cytotherapy · 2022 · 26 citations · Full text